References
- Stenman U H, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and α-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51: 222–26
- Lilja H, Christensson A, Dahln U, Matikainen M T, Nilsson O, Pettersson K, Lovgren T. Prostate-specific antigen in human serum occurs predominantly in complex with α-1-antichymotrypsin. ClinChem 1991; 37: 1618–25
- Lilja H. Significance of different molecular forms of serum PSA. The free, noncomplexed form of PSA versus that complexed to α-1-antichymotrypsin. Urol Clin N Amer 1993; 20(4)681–86
- Stamey T A, McNeal J E, Freiha F S, Redwine E A. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 1988; 139: 1235–41
- Stamey T A. Making the most out of six systematic sextant biopsies. Urology January, 1995; 45(1)
- Catalona W J, Richie J P, Ahmann F R, Hudson M A, Scardino P T, Flanigan R C, de Kemion J B, Ratliff T L, Kavoussi L R, Dakin B L, Waters W B, MacFarlane M T, Southwick P C. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6 630 men. J Urol 1994; 151: 1283–90